Millennium Management’s Edwards Lifesciences EW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$144M Sell
1,796,821
-4,284,117
-70% -$353M 0.06% 308
2025
Q4
$518M Buy
6,080,938
+4,301,241
+242% +$353M 0.22% 58
2025
Q3
$138M Sell
1,779,697
-4,902,303
-73% -$383M 0.06% 301
2025
Q2
$523M Buy
6,682,000
+3,237,236
+94% +$241M 0.25% 39
2025
Q1
$250M Buy
3,444,764
+3,216,598
+1,410% +$230M 0.13% 107
2024
Q4
$16.9M Sell
228,166
-912,893
-80% -$63.9M 0.01% 1665
2024
Q3
$75.3M Buy
1,141,059
+616,852
+118% +$44.8M 0.04% 577
2024
Q2
$48.4M Buy
524,207
+68,755
+15% +$6.09M 0.02% 813
2024
Q1
$43.5M Buy
455,452
+14,760
+3% +$1.24M 0.02% 919
2023
Q4
$33.6M Sell
440,692
-785,013
-64% -$54.6M 0.01% 1102
2023
Q3
$84.9M Sell
1,225,705
-271,379
-18% -$21.8M 0.04% 433
2023
Q2
$141M Buy
1,497,084
+31,912
+2% +$2.77M 0.07% 219
2023
Q1
$121M Sell
1,465,172
-3,068,983
-68% -$241M 0.07% 262
2022
Q4
$338M Buy
4,534,155
+2,227,180
+97% +$172M 0.19% 56
2022
Q3
$191M Buy
2,306,975
+2,261,902
+5,018% +$218M 0.11% 115
2022
Q2
$4.29M Sell
45,073
-169,524
-79% -$17.5M ﹤0.01% 2961
2022
Q1
$25.3M Buy
214,597
+58,429
+37% +$6.55M 0.01% 1154
2021
Q4
$20.2M Buy
156,168
+36,347
+30% +$4.24M 0.01% 1428
2021
Q3
$13.6M Sell
119,821
-894,320
-88% -$102M 0.01% 1695
2021
Q2
$105M Buy
1,014,141
+539,796
+114% +$50.9M 0.06% 277
2021
Q1
$39.7M Sell
474,345
-214,005
-31% -$18.1M 0.03% 625
2020
Q4
$62.8M Buy
688,350
+631,004
+1,100% +$52.3M 0.05% 355
2020
Q3
$4.58K Sell
57,346
-509,838
-90% -$39.8M 0.01% 1927
2020
Q2
$39.2M Buy
567,184
+475,462
+518% +$33.8M 0.05% 391
2020
Q1
$5.77M Sell
91,722
-1,260,546
-93% -$90.9M 0.01% 1226
2019
Q4
$105M Sell
1,352,268
-1,077,963
-44% -$84.2M 0.13% 134
2019
Q3
$178M Buy
2,430,231
+2,039,145
+521% +$143M 0.28% 39
2019
Q2
$24.1M Sell
391,086
-1,539,951
-80% -$93.1M 0.04% 682
2019
Q1
$123M Buy
1,931,037
+746,049
+63% +$42.6M 0.18% 101
2018
Q4
$60.5M Buy
1,184,988
+1,079,145
+1,020% +$54.6M 0.09% 278
2018
Q3
$6.14M Buy
105,843
+37,245
+54% +$1.82M 0.01% 1651
2018
Q2
$3.33M Sell
68,598
-1,513,125
-96% -$70.6M ﹤0.01% 2069
2018
Q1
$73.6M Sell
1,581,723
-874,113
-36% -$38M 0.1% 282
2017
Q4
$92.3M Sell
2,455,836
-1,563,282
-39% -$57.4M 0.13% 175
2017
Q3
$146M Sell
4,019,118
-31,584
-0.8% -$1.2M 0.22% 70
2017
Q2
$160M Buy
4,050,702
+1,371,231
+51% +$50.1M 0.28% 51
2017
Q1
$84M Buy
2,679,471
+2,317,971
+641% +$72.6M 0.15% 169
2016
Q4
$11.3M Sell
361,500
-2,308,557
-86% -$74.8M 0.02% 855
2016
Q3
$107M Sell
2,670,057
-873,300
-25% -$32.9M 0.18% 84
2016
Q2
$118M Buy
3,543,357
+3,199,299
+930% +$109M 0.27% 59
2016
Q1
$10.1M Sell
344,058
-1,539,375
-82% -$42.5M 0.03% 826
2015
Q4
$49.6M Sell
1,883,433
-5,191,227
-73% -$135M 0.1% 243
2015
Q3
$168M Sell
7,074,660
-385,608
-5% -$9.31M 0.32% 39
2015
Q2
$177M Buy
7,460,268
+677,742
+10% +$15.3M 0.34% 35
2015
Q1
$161M Buy
6,782,526
+2,587,464
+62% +$58M 0.3% 40
2014
Q4
$89.1M Buy
4,195,062
+4,195,038
+17,479,325% +$84.3M 0.19% 90
2014
Q3
$0 Sell
24
-1,919,700
-100% -$30.3M ﹤0.01% 3777
2014
Q2
$27.5M Buy
1,919,724
+1,442,490
+302% +$19.6M 0.08% 340
2014
Q1
$5.9M Buy
477,234
+271,674
+132% +$3.13M 0.02% 1117
2013
Q4
$2.25M Sell
205,560
-2,972,184
-94% -$33.5M 0.01% 1747
2013
Q3
$36.9M Buy
3,177,744
+2,906,430
+1,071% +$34M 0.12% 144
2013
Q2
$3.04M Buy
+271,314
New +$3.21M 0.01% 1324

Other funds holding EW

Millennium Management's EW Position: Q1 2026 in Review

Millennium Management reduced its Edwards Lifesciences (EW) stake by 70% in Q1 2026, selling an estimated $353M and leaving 1,796,821 shares worth $144M. The position accounts for 0.06% of the portfolio, ranked #308.

Millennium Management first reported a position in EW in Q2 2013 and has held it in 52 quarters since. The position peaked at $523M in Q2 2025. 1,283 funds tracked by Wall St. Rank hold EW as of Q1 2026.

  • Millennium Management held 1,796,821 shares of Edwards Lifesciences worth $144M as of Q1 2026.
  • Millennium Management sold 4,284,117 Edwards Lifesciences shares in Q1 2026, an estimated $353M.
  • Edwards Lifesciences made up 0.06% of Millennium Management's portfolio in Q1 2026, its #308 holding.
  • Millennium Management first reported a position in Edwards Lifesciences in Q2 2013 and has held it in 52 quarters since.
  • Millennium Management's Edwards Lifesciences position peaked at $523M in Q2 2025.
  • 1,283 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q1 2026.

Based on Millennium Management's 13F filing for Q1 2026, filed 15 May 2026.